News for Lava Therapeutics B.V. (LVTX)

Read Research Analysts’ Upgrades for April 23rd (ASX, BGFV, LIQT, LVTX, LYSDY, NGL, NWN, OLCLY, PSNL, RC) at ETF Daily News

Read LAVA Therapeutics (NASDAQ:LVTX) Lifted to Hold at Zacks Investment Research at ETF Daily News

Read Lava Therapeutics B.V. (NASDAQ:LVTX) Cut to Hold at Zacks Investment Research at ETF Daily News

Zacks Investment Research upgraded shares of Lava Therapeutics B.V. (NASDAQ:LVTX) from a sell rating to a buy rating in a report issued on Friday morning, Zacks.com reports. The brokerage currently has $5.50 price target on the stock. According to Zacks, “LAVA Therapeutics B.V. is a biotechnology company. It focuses on applying its expertise in bispecific […]

Gainers Nutriband Inc. (NASDAQ:NTRB) shares climbed 157.8% to close at $10.08 on Friday after the company announced the Korean Intellectual Pro...

We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC. The 13F filings show the funds’ and investors’ portfolio positions as of June 30th. In this article, we look at what those funds think of Marlin Business Services Corp. (NASDAQ:MRLN) based on […]

We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC.

Gainers IVERIC bio, Inc. (NASDAQ:ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au...